Integral Diagnostics Limited (ASX: IDX)

Market Cap	692.39M
Revenue (ttm)	469.70M
Net Income (ttm)	-60.70M
Shares Out	233.92M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	28.51
Dividend	0.06 (1.95%)
Ex-Dividend Date	Aug 30, 2024

Volume	367,715
Open	2.920
Previous Close	2.960
Day's Range	2.850 - 2.940
52-Week Range	1.640 - 3.200
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 20, 2024

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 1,977
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX